Artificial intelligence tool could speed stroke detection

The Food and Drug Administration has approved for marketing new decision support software that could alert doctors of a potential stroke in one of their patients. The software, which uses artificial intelligence, analyzes computed tomography results and notifies providers if findings of a stroke or potential stroke are detected. "The software device could benefit patients by notifying a specialist earlier, thereby decreasing the time to treatment," says Robert Ochs, acting deputy director for radiological health in FDA's Center for Devices and Radiological Health. The vendor is Viz.AI, born at Stanford University. Viz.AI is computer-aided triage software using an artificial intelligence algorithm to analyze images for indications associated with stroke.